Salvage surgery in head and neck cancer: Does it improve outcomes?

Author:

Patil Vijay Maruti,Noronha Vanita,Thiagarajan Shivakumar,Joshi Amit,Chandrasekharan Arun,Talreja Vikas,Agarwal Jaiprakash,Ghosh-Laskar Sarbani,Budrukkar Ashwini,Juvekar Shashikant,Mahajan Abhishek,Agarwal Archi,Purandare Nilendu,Bhattacharjee Atanu,D'Cruz Anil K.,Chaturvedi Pankaj,Pai Prathamesh S.,Chaukar Devendra,Prabhash Kumar

Funder

Biocon Ltd

Tata Memorial Center Research Administration Council

Fresenius Kabi India Pvt Ltd

Alkem Laboratories

Natco Pharma Ltd

BDR Pharmaceutics Intl Pvt Ltd

Roche Holding

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference25 articles.

1. Once-a-Week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial;Noronha;J Clin Oncol,2017

2. A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer;Patil;Cancer,2019

3. Once-a-week versus once-every-3-weeks cisplatin in patients receiving chemoradiation for locally advanced head-and-neck cancer: a survey of practice in India;Goyal;Canc Res Stat Treat,2018

4. Salvage surgery for head and neck cancer: a plea for better definitions;Sanabria;Eur Arch Oto-Rhino-Laryngol,2014

5. Outcomes after surgical salvage for recurrent oropharyngeal squamous cell carcinoma;Sweeny;Oral Oncol,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3